Psychosocial burden of patients with mycosis fungoides and Sézary syndrome compared to other dermatological patients. Pilot study. [PDF]
Cisoñ H +2 more
europepmc +1 more source
Case report of non-gene editing CD7 CAR T cell therapy in CD7<sup>+</sup> Sézary syndrome: preclinical validation and first-in-human use. [PDF]
Xu H +22 more
europepmc +1 more source
Systemic treatments with monoclonal antibodies in mycosis fungoides and Sézary syndrome. [PDF]
Ibatici A, Angelucci E, Massone C.
europepmc +1 more source
Sezary Syndrome: A Case Report and Review of Current Therapeutics. [PDF]
Krishnan J, Thanikachalam K.
europepmc +1 more source
A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States. [PDF]
Ristuccia R +7 more
europepmc +1 more source
Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs. [PDF]
Brazel D, Larocca C, Shinohara MM.
europepmc +1 more source
Could Residents Adequately Assess the Severity of Skin Lesions in Mycosis Fungoides/Sézary Syndrome? Evaluation of Interrater Agreement and Interrater Reliability of mSWAT. [PDF]
Cisoń H +2 more
europepmc +1 more source
Response to Campbell et al.'s comments on our study "Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study". [PDF]
Bozonnat A +5 more
europepmc +1 more source
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. [PDF]
Jiang TT, Kruglov O, Akilov OE.
europepmc +1 more source

